Category | Non-cancerous | Benign ovarian condition | Early stage serous ovarian cancer | Late stage serous ovarian cancer | Total |
---|---|---|---|---|---|
n | 18 | 18 | 16 | 17 | 69 |
Age range (median) | 50–83 (62.5) | 36–81 (49) | 42–83 (61) | 53–75 (65) | 36–83 (60) |
Race (%) | Â | Â | Â | Â | Â |
 Caucasian | 5 | 17 | 13 | 17 | 52 (75.4%) |
 African American | 1 |  |  |  | 5 (7.2%) |
 Unidentified | 12 |  |  |  | 12 (17.4%) |
Stage I | Â | Â | 10 | Â | Â |
Stage II | Â | Â | 6 | Â | Â |
Stage III | Â | Â | Â | 15 | Â |
Stage IV | Â | Â | Â | 2 | Â |
CA125 range (median)* | 0–69 (1.55) | 6–413 (14.5) | 32–22780 (108) | 124–3417 (584) |  |